Literature DB >> 18471751

Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.

Cristiano Boneti1, Soheila Korourian, Keiva Bland, Kristin Cox, Laura L Adkins, Ronda S Henry-Tillman, V Suzanne Klimberg.   

Abstract

BACKGROUND: Several recent reports have shown a lymphedema rate of about 7% with sentinel lymph node biopsy (SLNB) only. We hypothesized that this higher than expected rate of lymphedema may be secondary to disruption of arm lymphatics during an SLNB procedure. STUDY
DESIGN: This IRB-approved study, from May 2006 to June 2007, involved patients undergoing SLNB with or without axillary lymph node dissection. After sentinel lymph node (SLN) localization with subareolar technetium was assured, 2 to 5 mL of dermal blue dye was injected in the upper inner arm for localization of lymphatics draining the arm (axillary reverse mapping, ARM). The SLNB was then performed through an incision in the axilla. Data were collected on identification rates of hot versus blue nodes, variations in ARM lymphatic drainage that might impact SLNB, crossover between the hot and the blue lymphatics, and final pathologic nodal diagnosis.
RESULTS: Median age was 57.6+/-12.5 years. Lymphatics draining the arm were near or in the SLN field in 42.7% (56 of 131) of the patients, placing the patient at risk for disruption if not identified and preserved during an SLNB or axillary lymph node dissection. ARM demonstrated that arm lymphatics do not cross over with the SLN drainage of the breast 96.1% of the time and that none of the ARM lymph nodes removed were positive, even when the SLN was (5 of 12). Seven (5.5%) blue ARM lymphatics were juxtaposed to the hot SLNBs.
CONCLUSIONS: Disruption of the blue ARM node because of proximity to the hot SLN may explain the surprisingly high rate of lymphedema seen after SLNB. Identifying and preserving the ARM blue nodes may translate into a lower incidence of lymphedema with SLNB and axillary lymph node dissection.

Entities:  

Mesh:

Year:  2008        PMID: 18471751     DOI: 10.1016/j.jamcollsurg.2007.12.022

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  24 in total

1.  Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients.

Authors:  Heran Deng; Lun Chen; Weijuan Jia; Kai Chen; Yunjie Zeng; Nanyan Rao; Shunrong Li; Liang Jin; Fengxi Su
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-21       Impact factor: 4.553

2.  Lymphatic complications in surgery: possibility of prevention and therapeutic options.

Authors:  Francesco Boccardo; Corrado Cesare Campisi; Lidia Molinari; Sara Dessalvi; Pier Luigi Santi; Corradino Campisi
Journal:  Updates Surg       Date:  2012-07-21

3.  A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.

Authors:  Isabelle Bedrosian; Gildy V Babiera; Elizabeth A Mittendorf; Henry M Kuerer; Laura Pantoja; Kelly K Hunt; Savitri Krishnamurthy; Funda Meric-Bernstam
Journal:  Cancer       Date:  2010-06-01       Impact factor: 6.860

Review 4.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

Review 5.  Recent progress in the treatment and prevention of cancer-related lymphedema.

Authors:  Simona F Shaitelman; Kate D Cromwell; John C Rasmussen; Nicole L Stout; Jane M Armer; Bonnie B Lasinski; Janice N Cormier
Journal:  CA Cancer J Clin       Date:  2014-11-19       Impact factor: 508.702

6.  The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer.

Authors:  Jung Woo Han; Yu Jeong Seo; Jung Eun Choi; Su Hwan Kang; Young Kyung Bae; Soo Jung Lee
Journal:  J Breast Cancer       Date:  2012-03-28       Impact factor: 3.588

7.  Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction.

Authors:  Mei R Fu; Yvette P Conley; Deborah Axelrod; Amber A Guth; Gary Yu; Jason Fletcher; David Zagzag
Journal:  Breast       Date:  2016-07-22       Impact factor: 4.380

8.  mHealth self-care interventions: managing symptoms following breast cancer treatment.

Authors:  Mei R Fu; Deborah Axelrod; Amber A Guth; Kavita Rampertaap; Nardin El-Shammaa; Karen Hiotis; Joan Scagliola; Gary Yu; Yao Wang
Journal:  Mhealth       Date:  2016-07-22

9.  Best Practice Guidelines in Assessment, Risk Reduction, Management, and Surveillance for Post-Breast Cancer Lymphedema.

Authors:  Jane M Armer; Jennifer M Hulett; Michael Bernas; Pam Ostby; Bob R Stewart; Janice N Cormier
Journal:  Curr Breast Cancer Rep       Date:  2013-06

Review 10.  Combining Autologous Breast Reconstruction and Vascularized Lymph Node Transfer.

Authors:  Edward I Chang; Jaume Masià; Mark L Smith
Journal:  Semin Plast Surg       Date:  2018-04-09       Impact factor: 2.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.